This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Jan;117(1):8-9.

doi: 10.1111/bju.13119.

Doubling our precision of risk stratification in early prostate cancer: too good to be true?

Mark Emberton¹

Affiliations

PMID: 26676679
DOI: 10.1111/bju.13119

Comment

Doubling our precision of risk stratification in early prostate cancer: too good to be true?

Mark Emberton. BJU Int. 2016 Jan.

. 2016 Jan;117(1):8-9.

doi: 10.1111/bju.13119.

Author

Mark Emberton¹

Affiliation

¹ Division of Surgery and Interventional Science, University College London, London, UK.

PMID: 26676679
DOI: 10.1111/bju.13119

No abstract available

PubMed Disclaimer

Comment on

Combination of multiparametric MRI and transperineal template-guided mapping biopsy of the prostate to identify candidates for hemi-ablative focal therapy.
Tran M, Thompson J, Böhm M, Pulbrook M, Moses D, Shnier R, Brenner P, Delprado W, Haynes AM, Savdie R, Stricker PD. Tran M, et al. BJU Int. 2016 Jan;117(1):48-54. doi: 10.1111/bju.13090. Epub 2015 May 11. BJU Int. 2016. PMID: 25682968

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information